|Home | About | Journals | Submit | Contact Us | Français|
Nuclear factor erythroid 2–related factor 2 (Nrf2) is a transcription factor that is important in protection against oxidative stress. This study was designed to determine the role of Nrf2 signaling in transcriptional activation of detoxifying and antioxidant genes in an in vivo mouse fetal alcohol syndrome model. Maternal ethanol treatment was found to increase both Nrf2 protein levels and Nrf2-ARE binding in mouse embryos. It also resulted in a moderate increase in the mRNA expression of Nrf2 downstream target detoxifying and antioxidant genes as well as an increase in the expression of antioxidant proteins. Pretreatment with the Nrf2 inducer, 3H-1,2 dithiole-3-thione (D3T), significantly increased Nrf2 protein levels and Nrf2-ARE binding, and strongly induced the mRNA expression of Nrf2 downstream target genes. It also increased the expression of antioxidant proteins and the activities of the antioxidant enzymes. Additionally, D3T pretreatment resulted in a significant decrease in ethanol-induced reactive oxygen species generation and apoptosis in mouse embryos. These results demonstrate that Nrf2 signaling is involved in the induction of antioxidant response in ethanol-exposed embryos. In addition, the potency of D3T in inducing antioxidants as well as in diminishing ethanol-induced apoptosis suggests that further exploration of the antiteratogenic effect of this compound will be fruitful. Antioxid. Redox Signal. 11, 2023–2033.
Fetal alcohol spectrum disorders (FASD) are among the most devastating consequences of the widespread use and abuse of alcohol (ethanol). FASD is an umbrella term that includes full-blown fetal alcohol syndrome (FAS) as the severe end of the spectrum of alcohol-induced birth defects. Prenatal ethanol exposure is considered to be the leading known cause of mental retardation in the Western world (1). According to a 1996 Institute of Medicine (IOM) report, the prevalence of FAS in the United States has been estimated at 0.5 to 3.0 cases per 1,000 births, with the full spectrum of ethanol-induced prenatal insult projected to occur several times as frequently (39).
Apoptotic death of selected cell populations is a commonly observed pathogenic feature of ethanol-induced teratogenesis in both in vivo and in vitro model systems (3, 7, 11, 14, 37, 40). Among the proposed mechanisms underlying ethanol-induced apoptosis and malformation is oxidative stress. This is evidenced in studies from our laboratory and others that have shown that (a) antioxidants significantly improve the viability of an ethanol-sensitive cell population, neural crest cells, in vitro (9, 10); (b) ethanol induces superoxide anion generation and lipid peroxidation in cultured mouse embryos (24); (c) superoxide dismutase (SOD) can diminish ethanol-induced cell death and significantly reduce the incidence of neural tube defects (24); and (d) EUK-134, a synthetic SOD and catalase mimetic, can reduce apoptosis and the resulting limb defects in mouse embryos exposed to ethanol in vivo (8).
In addition to using exogenous antioxidants to reduce oxidative stress in ethanol-exposed embryos, a proposed strategy for protecting against oxidative damage entails chemically mediated upregulation of endogenous antioxidants. The current study describes modulation of Nrf2, which is a transcription factor that regulates the induction of detoxifying and antioxidant genes through antioxidant response element (ARE) and, thus, plays a central role in the cellular defense against oxidative stress. Protection mediated by Nrf2 signaling is evidenced by its role in reduction of oxidative damage induced by acute pulmonary injury and hyperoxia (6, 12). Additionally, Nrf2 deficiency enhances the sensitivity of neurons and astrocytes to oxidative stress by reducing the expression of cytoprotective genes (27, 28). Nrf2-deficient mice form higher levels of DNA adducts after exposure to carcinogens (36). A number of studies have also shown that Nrf2 plays an important role in cell survival (27, 28, 30).
Because Nrf2 plays a key role in the transcriptional induction of various antioxidants (21) and an expansive set of antioxidant/detoxification genes that act in synergy to remove ROS is essential for efficient detoxification of ROS, identification of molecules that can induce Nrf2 activation has recently received considerable attention. A wide variety of natural and synthetic small molecules are potent inducers of Nrf2 activity (32). Among these molecules is 3H-1,2 dithiole-3-thione (D3T). D3T is a potent cancer chemopreventive agent that protects against mutation and initiation of neoplasia (34). In addition, activation of the Nrf2 pathway by oral administration of D3T has recently been reported to confer partial protection against MPTP-induced neurotoxicity (4). The protective effects of D3T in animals have been associated with induction of the detoxifying and antioxidant enzymes SOD, catalase and γ-glutamylcysteine synthetase (γ-GCS) (5, 31, 34). Although the exact mechanisms by which D3T activates Nrf2 signaling remain to be defined, it was suggested that the direct interaction between D3T and the sulfhydryl groups of Keap1 can cause dissociation of Keap1 from Nrf2, leading to Nrf2 activation (26). In addition, mitogen-activated protein kinases (MAPKs) have recently been shown to be involved in the activation of Nrf2 by D3T (29).
Although it is clear that Nrf2 is a key transcription factor in regulating a variety of cytoprotective genes in various types of cells and tissues, the potential for this signaling pathway to play a significant protective role relative to teratogenesis by ethanol has not been previously investigated. This study was designed to fill this void by examination of Nrf2-mediated transcriptional activation of detoxifying and antioxidant genes in ethanol-exposed mouse embryos, along with examination of the protective effect of the Nrf2 inducer, D3T. To this end, we have examined the levels of Nrf2 protein and Nrf2-ARE binding activity and have analyzed mRNA and protein expression of Nrf2 downstream target genes as well as the activities of antioxidant enzymes in mouse embryos after exposure to ethanol and D3T in vivo. Additionally, we have determined the potential of D3T to prevent ethanol-induced oxidative stress and apoptosis in mouse embryos. The results of this study demonstrate that Nrf2 signaling is involved in the induction of antioxidants and detoxifying enzymes in ethanol-exposed mouse embryos and that D3T pretreatment can induce antioxidant proteins and phase 2 enzymes and prevent ethanol-induced apoptosis.
C57BL/6J mice (The Jackson Laboratory, Bar Harbor, ME) were mated for 2h early in the light cycle. The time of vaginal-plug detection was considered 0 days, 0h of gestation (GD 0:0). Mice were maintained on an ad libitum diet of breeder chow and water. Animals in the experimental groups were administered two intraperitoneal (i.p.) doses of 25.0% (vol/vol) ethanol in lactated Ringer's solution at a dosage of 2.9g/kg maternal body weight. Control dams were administered lactated Ringer's solution alone. The injections were given 4h apart, with the first administered at GD 8:0. For D3T pretreatment, pregnant mice were given i.p. injections of either D3T (LKT Laboratories, Inc., St. Paul, MN) at a dosage of 5mg/kg or its solvent (vegetable oil) on GD 7:6 (i.e., 18h before they were treated with ethanol or Ringer's solution). For mRNA and protein analysis, pregnant females were killed by cervical dislocation on GD 8:6 (6h after the first ethanol treatment). For apoptosis assays, pregnant mice were killed on GD 8:12 (12h after the first ethanol treatment). Abdominal cavities were surgically opened, and the uteri were exposed and removed. Embryos were dissected free of their deciduas in lactated Ringer's solution and then staged by counting the number of somite pairs. Embryos of comparable developmental stage from several litters were pooled for mRNA and protein preparation. Selection of the time points at which analyses were conducted was based on our previous investigations, which demonstrated that significant changes in mRNA expression can be observed by microarray assay in ethanol-exposed mouse embryos as early as 3h after the first ethanol treatment (18) and that excessive apoptosis can be observed in ethanol-exposed mouse embryos 12–16h after initial treatment with ethanol (8, 14, 25). All protocols used in this study were approved by the University of North Carolina at Chapel Hill Institutional Animal Care and Use Committee.
Total RNA was isolated from whole embryos by using Trizol reagent (Invitrogen, CA) and cleaned with Qiagen RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. RNA quantitation was performed by measuring the absorbance of the RNA sample solutions at 260nm. The RNA integrity was determined by agarose gel electrophoresis. The RNA samples were treated with DNase-I (Qiagen RNase-free DNase kit). The reverse transcription reaction was carried out in a 100-μl reaction by incubation of 1 μg of RNA with Oligo d(T)16 primers at 48°C for 60min, by using a commercially available GeneAmp RNA PCR kit (Applied Biosystems, Foster, CA).
Quantitative real-time PCR with SYBR green I detection (Applied Biosystems, Warrington, U.K.) was performed in a MyiQ Single-Color Real-Time PCR Detection System (Bio-Rad Laboratories, Hercules, CA). Primers listed in Table 1 were designed by using Primer Express Software (Applied Biosystems) and synthesized by Integrated DNA Technologies, Inc (Coralville, IA). Reactions were performed in a total volume of 25 μl, including 12.5 μl 2×Power SYBR Green PCR Master Mix, 1 μl of 0.4 μM primer, and 2.5 μl of the previously reverse-transcribed cDNA template on 96-well iCycler iQ PCR plates (Bio-Rad). All reactions were carried out at least in duplicate for each sample. The thermocycling profile included 45 cycles consisting of denaturation at 95°C for 15sec, and annealing and elongation at 60°C for 60sec. Melting curve and agarose electrophoresis analysis were performed to exclude amplification of nonspecific products. GAPDH was used as a reference for normalization, and relative quantification was performed by using iCycler iQ Optical System Software Version 1 (Bio-Rad).
Embryos were washed once in phosphate-buffered saline (PBS) and lysed by incubation for 30min in RIPA lysis buffer (PBS, 0.5 % sodium deoxycholate, 1% NP-40, 0.1% SDS, 1mM dithiothreitol) with 1mM PMSF and protease cocktail inhibitors (Roche, Indianapolis, IN). The samples were then centrifuged at 16,000 g for 10min at 4°C. The collected supernatants were used for Western blotting. The protein concentration in each sample was measured by using Bio-Rad Protein Assay Reagent (Bio-Rad Laboratories) according to the manufacturer's instructions. Western blots were performed by standard protocols. In brief, total protein (20 μg each lane) was resolved on an SDS–10% polyacrylamide gel and transferred to nitrocellulose membranes. The levels of Nrf2, catalase, and SOD1 and SOD2 proteins were analyzed with the following antibodies: rabbit polyclonal anti-Nrf2 IgG (1:500, Santa Cruz, Santa Cruz, CA), mouse monoclonal anti-catalase antibody (1:500; Sigma, St. Louis, MO), rabbit polyclonal anti-SOD1 IgG (1:1,000; Santa Cruz), and rabbit polyclonal anti-SOD2 IgG (1:500; Santa Cruz), respectively, followed by detection with ECL plus Western-blotting detection reagents (GE Healthcare, Piscataway, NJ). The membranes were scanned on a Bio-Rad Versa Doc Imaging System (model 4000), and the intensity of the protein bands was analyzed by using the Bio-Rad Quantity One software (version 4.5.1).
Nrf2-ARE binding was determined using an electrophoretic mobility shift assay (EMSA). Nuclear extracts were prepared from control and treated mouse embryos by using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Pierce Biotechnology, Rockford, IL) by following the manufacturer's protocol. Binding reactions containing equal amounts of protein (5 μg) and labeled double-strand oligonucleotide probe for mouse glutamate-cysteine ligase (GCLC) ARE (5′-GCACAAAGCGCTGAGTCACGGGGAGG-3′; 5′-GTCCCCGTGACTCAGCGCTTTGTGCG-3′; core ARE sequence underlined) were performed for 20min at room temperature. Specific binding was confirmed by using 100-fold excess unlabeled ARE oligonucleotide as a specific competitor (Gel Shift Assay Kit; Promega, Madison, WI). The oligonucleotide–protein complex was separated by 4% nondenaturing polyacrylamide gel electrophoresis followed by autoradiography. All gel-shift assays were performed for three sample replicates in each group.
Mouse embryos were collected and placed in ice-cold PBS buffer, pH 7.4. The embryos were sonicated, followed by centrifugation at 13,000 g for 10min at 4°C. The supernatants were collected for measurement of antioxidant enzymes. Total superoxide dismutase (SOD) activity was determined with the SOD Assay Kit from Dojindo Molecular Technologies, Inc. (Gaithersburg, MD) according to the manufacturer's protocol. Catalase activity was measured with an Amplex Red Catalase Assay Kit (Molecular Probes, Eugene, OR) according to the manufacturer's instruction.
Intracellular ROS generation was assayed with the method described by Ozawa et al. (35), with modification. The mouse embryos were washed twice in assay buffer (130mM KCl, 5mM MgCl2, 20mM NaH2PO4, 20mM Tris-HCl, 30mM glucose) and homogenized in 100 μl of assay buffer. The homogenate was centrifuged at 10,000 g for 15min at 4°C, and the supernatant, which was equivalent to 40 μg of protein, was transferred to a 96-well microplate. Assay buffer and 2 μl of 2′,7′-dichlorodihydro-fluoroscein diacetate (DCHFDA; Molecular Probes, Inc., Eugene, OR) (5mM in DMSO) were added to the microplate to give a total reaction volume of 200 μl. Subsequently, the samples were incubated at 37°C for 15min. The fluorescence intensity was monitored for 30min after excitation at 485nm and emission at 535nm by using a CytoFlor fluorescence plate reader (Perseptive Biosystems, Foster City, CA). The protein concentration in each sample was measured by using Bio-Rad Protein Assay Reagent (Bio-Rad Laboratories, Inc.), according to the manufacturer's instructions. The ROS level was expressed as relative fluorescence intensity units.
Apoptosis was determined in mouse embryos 12h after initial maternal ethanol exposure by using two independent assays, caspase-3 activation and Nile blue sulfate vital staining. Caspase-3 activation was analyzed with Western blot. For this assay, protein preparation and Western blot were conducted as described earlier. The activation of caspase-3 was analyzed with rabbit polyclonal against cleaved caspase-3 (Asp 175) (1:500; Cell Signaling Technology, Danvers, MA). The extent of apoptosis was expressed as fold change in caspase-3 activation over control. Caspase-3 activity was determined with fluorimetric assay by using the substrate Ac-DEVD-AMC (Caspase-3 Cellular Activity Assay Kit; Calbiochem, San Diego, CA) according to the manufacturer's instructions. Nile blue sulfate staining was carried out in whole embryos, as described previously (11). In brief, embryos were incubated in a 1:50,000 solution of Nile blue sulfate in Ringer's solution at 37°C for 30min. Stained specimens were then washed in Ringer's solution and immediately photographed by using an Olympus dissecting photomicroscope. Both experimental and control embryos were processed simultaneously for visual comparison of patterns of cell death. Approximately 10 to 15 embryos for both experimental and control groups were examined.
Statistical analyses were performed by using StatView software (SAS Institute Inc., Cary, NC). All data are expressed as mean±SEM of three separate experiments. Statistical comparisons between groups were analyzed with a one-way ANOVA. Multiple comparison post-tests between groups were conducted by using a Tukey test. Differences between control and treated groups, or between ethanol-treated group and other groups, were considered significant at p<0.05.
To examine the effects of ethanol on Nrf2 signaling in GD 8 mouse embryos, pregnant mice were administered two intraperitoneal (i.p.) doses of 25.0% (vol/vol) ethanol at a dosage of 2.9g/kg maternal body weight on GD 8. This dose of ethanol produced a peak maternal blood alcohol level (BAL) of~500mg/dl 4.5h after the initial dose. At 6h after the first dose, the time at which Nrf2 protein level was analyzed, the maternal BAL is~400mg/dl (42). Western blot analysis revealed a moderate increase in the level of Nrf2 protein in mouse embryos exposed to ethanol in vivo (p<0.05) (Fig. 1).
A major focus of the current study was to examine the potential protective property of the Nrf2 inducer, D3T. To this end, the effects of in vivo D3T administration on the expression of Nrf2 and its downstream phase 2 enzymes and antioxidant proteins were determined. Pregnant mice were administered D3T 18 hours before ethanol treatment. Western blot analyses illustrated a 2.8-fold increase in Nrf2 protein in the embryos whose dams had been treated with both ethanol and D3T (Fig. 1).
The antioxidant response element (ARE) is a transcriptional regulatory element involved in the activation of genes coding for a number of antioxidant proteins and phase 2 detoxifying enzymes. To further substantiate that treatment with ethanol and D3T can activate Nrf2, we examined the Nrf2-ARE binding activity in mouse embryos exposed to ethanol and D3T. EMSA with an oligonucleotide probe for mouse GCLC ARE showed an increased Nrf2-ARE binding activity in mouse embryos exposed to ethanol for 6h. Pretreatment with D3T resulted in a significantly greater increase in Nrf2-ARE binding activity in ethanol-exposed mouse embryos than that in mouse embryos in control and ethanol-treated groups (Fig. 2). These data demonstrate that Nrf2 signaling is involved in ethanol-exposed mouse embryos and that it can be induced by Nrf2 inducer in mouse embryos.
To examine the effects of ethanol on the expression of antioxidant genes that are downstream of Nrf2, mRNA and protein expression were analyzed by using real-time PCR and Western blot, respectively. As indicated by mRNA level, ethanol exposure for 6h increased the expression of antioxidant genes, including cytoplasmic superoxide dismutase (SOD1), mitochondrial superoxide dismutase (SOD2), extracellular superoxide dismutase (SOD3), catalase (CAT), glutathione reductase (GSR), thioredoxin (TRX), and glutathione peroxidase 1 and 3 (Gpx1 and Gpx3). Except for SOD3, which was increased by threefold, changes in the mRNA level for the remainder of the genes tested in this study were less than onefold over control, indicating that ethanol treatment alone can induce only a moderate increase in antioxidant gene expression (Fig. 3). Western blot analysis also illustrated a moderate increase in the expression of SOD1, SOD2, and catalase protein (Fig. 4), confirming the corresponding changes in major antioxidant proteins that accompany mRNA induction.
Pretreatment with D3T resulted in a significantly greater increase in mRNA and protein expression of antioxidants. Pretreatment with D3T significantly increased the mRNA expression of antioxidant genes, including SOD1, SOD2, SOD3, CAT, Trx, Gpx1, Gpx2, Gpx3, and GSR in ethanol-exposed embryos (p<0.05). Among these antioxidant genes, the expression of SOD1, SOD2, SOD3, and Gpx3 was increased by four-, three-, seven-, and threefold, respectively, in ethanol-exposed embryos pretreated with D3T as compared with control (Fig. 3). Significant increases in expression of the major antioxidant proteins SOD1, SOD2, and catalase were also observed in ethanol-exposed mouse embryos pretreated with D3T (Fig. 4).
Nrf2 controls genes encoding phase 2 detoxifying enzymes and antioxidant proteins. The orchestrated induction of these proteins, which is referred to as an Nrf2-mediated defense response, is crucial for cells in counteracting the adverse effects of exogenous insults. To test whether upregulation of Nrf2 by ethanol or D3T can increase the catalytic activity of selected antioxidant enzymes in mouse embryos, the activities of two prototypic antioxidant enzymes, SOD and CAT, were analyzed. As shown in Fig. 5, ethanol exposure for 6 hours resulted in increases in the activities of SOD and CAT. Pretreatment with D3T resulted in a significantly greater increase in the activities of SOD and CAT in ethanol-exposed mouse embryos than the group treated with ethanol alone (Fig. 5), confirming the corresponding changes in the activities of major antioxidant enzymes that accompany mRNA and protein induction.
Phase 2 detoxifying enzymes are involved in the detoxification of electrophilic chemicals, including carcinogens and cardiovascular toxicants. To explore whether phase 2 enzymes can also be induced by in vivo ethanol exposure in early mouse embryos, mRNA expression of the genes encoding phase 2 enzymes was analyzed by using real-time PCR. As shown in Fig. 6, treatment of early mouse embryos with ethanol for 6h in vivo increased the mRNA expression of NAD(P) H:quinone oxidoreductase-1(NQO-1) and glutathione S-transferase (GSTa2, GSTm2, GSTm3, and GSTp1). However, similar to ethanol-induced changes in antioxidant gene expression, for most of these genes, the changes in the mRNA level caused by ethanol alone were less than or close to onefold over control. A significantly greater increase in the mRNA levels of the genes encoding phase 2 enzymes was observed in ethanol-exposed embryos pretreated with D3T as compared with both the control group and the groups treated with ethanol alone (p<0.05) (Fig. 6).
For analysis of the effects of D3T pretreatment on ROS generation in mouse embryos exposed to ethanol in vivo, a 2′,7′-dichlorodihydro-fluoroscein diacetate (DCHFDA) assay was used. Exposure of mouse embryos to ethanol for 6h in vivo significantly increased ROS generation, confirming that ethanol can induce ROS generation in early mouse embryos. Pretreatment with D3T significantly reduced ROS generation in mouse embryos exposed to ethanol in vivo (Fig. 7), supporting the premise that chemically induced transcriptional activation of Nrf2 and subsequent induction of detoxifying and antioxidant proteins can reduce ethanol-induced oxidative stress in early mouse embryos.
To determine the effects of D3T treatment on ethanol-induced apoptosis in early mouse embryos, the effect of D3T on the activation of caspase-3 was examined. As shown in Fig. 8A, in control embryos, caspase-3 exists as procaspase-3 (37kDa), and little active caspase-3 was observed. In vivo ethanol treatment induced the activation of caspase-3 in mouse embryos, as evidenced by a twofold increase in the expression of its 17-kDa subunit and also resulted in a significant increase in the activity of this protease (Fig. 8B). Pretreatment with D3T resulted in a significant reduction in the activation and activity of caspase-3 in ethanol-exposed mouse embryos as compared with the group treated with ethanol alone.
Although the caspase-3 activation assay allows rapid quantification of apoptosis, it precludes localization of apoptosis in whole embryos. For this, Nile blue sulfate staining was used in conjunction with caspase-3 activation assay to confirm the occurrence and to determine the locations of apoptosis in whole embryos. As expected, compared with the untreated and D3T-treated control embryos, those exposed to ethanol showed excessive Nile blue sulfate staining. The pattern and amount of stain uptake in the ethanol-exposed embryos was typical of that previously reported for this exposure paradigm (14). Pretreatment with D3T dramatically reduced the ethanol-induced increase in Nile blue sulfate staining (Fig. 9), indicating that pretreatment with D3T is, indeed, effective in preventing ethanol-induced apoptosis in mouse embryos.
Utilizing a mouse FASD model, this study provided the first evidence that in vivo ethanol exposure can activate the Nrf2 pathway in early embryos. Activation of Nrf2 results in upregulation of Nrf2 downstream target genes, including those that encode phase 2 detoxifying enzymes and antioxidant proteins such as NQO1, GST, SOD, CAT, TRX, GPx, and GSR. In addition to gene expression changes, Western blot analysis revealed a moderate increase in the expression of Nrf2 and the antioxidant proteins SOD1, SOD2, and catalase, as well as the activities of the antioxidant enzymes, SOD, and catalase in ethanol-exposed mouse embryo. Because exposure of embryos to ethanol results in the generation of ROS, which are known to activate Nrf2 (21), the observed Nrf2 activation was expected. This response is not unique to ethanol-exposed embryos. Similar effects have been observed in cells treated with a numbers of other toxic chemicals, including heavy metals (19, 23), cigarette smoke (22), and arachidonic acid (17). Of particular interest to this study is that an increase in Nrf2 protein has also been observed in livers and hepatocytes of alcohol-fed mice and rats (16).
Most eukaryotic cells possess inherent antioxidant defense mechanisms that include both nonenzymatic neutralization and enzymatic detoxification of oxygen-derived radicals and other reactive species (15). However, early mouse embryos might be expected to have only minimal antioxidant capabilities because the amount of O2 that they metabolize is very low. Indeed, studies by Davis et al. (13) provided evidence that neural crest cells cultured from chick embryos have a deficiency of SOD. The present study showed that Nrf2 is activated in response to ethanol challenge, leading to the transcriptional induction of many antioxidant genes. The teratogenic outcome of ethanol exposure is expected to be determined by the balance between the induced ROS production and the antioxidant capability, as regulated by Nrf2. The fact that excessive apoptosis and dysmorphology result from the exposure regimen used for the present investigation (11, 14) suggests that the ethanol-induced activation of Nrf2 and its downstream antioxidants is an adaptive response that is insufficient to be protective. This is supported by this study's finding that ethanol can induce only a moderate increase in antioxidant and detoxifying gene expression.
One of the promising strategies for protection against oxidative stress that has received considerable attention is supplementation with exogenous antioxidants. We showed previously that exogenous antioxidants, including SOD, catalase, vitamin E, N-acetylcysteine, and EUK-134, a synthetic SOD and catalase mimetic, significantly diminish apoptosis and subsequent dysmorphology in early mouse embryos exposed to ethanol in vitro and in vivo (8–10, 24). Additionally, Spong et al. (38) have shown that NAP, a neuroprotective peptide that has been shown to exhibit antioxidant actions, can decrease ethanol-induced depletion of reduced glutathione and fetal death. However, the protection provided by exogenous antioxidants is not complete. In addition to the fact that teratogenic mechanisms other than oxidative damage may be involved in the teratogenic effects of ethanol, the incomplete protection points to the limitations associated with the use of exogenous antioxidants. The therapeutic efficacy of exogenous antioxidants may be limited by the facts that (a) their systemic delivery might not provide adequate concentrations in the target tissue(s), (b) many antioxidants have very limited passage through a variety of cellular structures and barriers, and (c) limited numbers of exogenous antioxidants can be simultaneously administrated to embryos. In this regard, a more promising strategy for protecting against oxidative injury and ethanol's teratogenesis may be through coordinated upregulation by chemical inducers of a broad spectrum of endogenous antioxidants/phase 2 enzymes in embryonic tissue. As shown by the results of the current study, D3T is effective in this role.
D3T was shown in this study to induce Nrf2 potently in mouse embryos. It significantly increased Nrf2 protein levels and Nrf2-ARE binding activity, and strongly induced the mRNA expression of Nrf2 downstream target genes. Pretreatment with D3T also increased the expression of antioxidant proteins and the activities of antioxidant enzymes, and significantly reduced ROS generation in mouse embryos exposed to ethanol in vivo. In addition, it significantly decreased ethanol-induced activation and activity of caspase-3. Caspase-3 is a key effector in the apoptosis pathway, amplifying the signal from initiator caspases; with its activation signifying full commitment to cellular disassembly (41). The presence of activated caspase-3 has been identified as a marker for active apoptosis (2). Caspase-3 activation has been observed in apoptosis caused by various inducers, including ethanol. For example, ethanol exposure of 7-day postnatal mice has previously been shown to result in caspase-3 activation in a pattern that corresponds to the pattern of apoptotic neurodegeneration (20, 33). The significant decrease in ethanol-induced caspase-3 activation and activity in mouse embryos pretreated with D3T suggests that this compound can reduce ethanol-induced apoptosis in early mouse embryos. This was shown to be the case, as indicated by dramatically reduced Nile blue sulfate staining in ethanol-exposed embryos pretreated with D3T. These results demonstrated that this Nrf2 inducer is indeed effective in preventing oxidative stress and apoptosis in mouse embryos exposed to ethanol in vivo.
In conclusion, this study demonstrates that Nrf2 signaling is involved in the induction of antioxidants and detoxifying enzymes in ethanol-exposed mouse embryos. These findings provide important information regarding the molecular mechanisms of ROS signaling and the endogenous cellular antioxidant defense systems involved in coping with ethanol-induced oxidative stress and cell damage. Although further study regarding the developmental toxicology of D3T is required, the potency of this agent in inducing antioxidant response as well as in preventing ethanol-induced apoptosis suggests that further exploration of its antiteratogenic effect may yield novel strategies for prevention of ethanol-induced birth defects.
This work is supported by NIH grants AA017446 (S.-Y.C.), AA013908 (S.-Y.C.), AA11605 (K.K.S), and AA12974 from the National Institute on Alcohol Abuse and Alcoholism.
ARE, antioxidant response element; CAT, catalase; D3T, 3H-1, 2 dithiole-3-thione; FAS, fetal alcohol syndrome; FASDs, fetal alcohol spectrum disorders; GD, gestational day; Gpx, glutathione peroxidase; GSR, glutathione reductase; GST, glutathione S-transferase; MPTP, 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine; NCCs, neural crest cells; NQO-1, NAD(P)H:quinone oxidoreductase-1; Nrf2, nuclear factor erythroid 2–related factor 2; ROS, reactive oxygen species; SOD1, cytoplasmic superoxide dismutase; SOD2, mitochondrial superoxide dismutase; SOD3, extracellular superoxide dismutase; TRX, thioredoxin; TUNEL, terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling.